These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9061333)

  • 21. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
    Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
    [No Abstract]   [Full Text] [Related]  

  • 22. K-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome.
    Semczuk A; Berbeć H; Kostuch M; Cybulski M; Wojcierowski J; Baranowski W
    J Cancer Res Clin Oncol; 1998; 124(12):695-700. PubMed ID: 9879831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.
    Pijnenborg JM; Dam-de Veen GC; Kisters N; Delvoux B; van Engeland M; Herman JG; Groothuis PG
    Ann Oncol; 2007 Mar; 18(3):491-7. PubMed ID: 17170014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
    Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
    Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-ras point mutations in spontaneously occurring endometrial adenocarcinomas in the Donryu rat.
    Tanoguchi K; Yaegashi N; Jiko K; Maekawa A; Sato S; Yajima A
    Tohoku J Exp Med; 1999 Oct; 189(2):87-93. PubMed ID: 10775052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: lack of correlation with established prognostic factors.
    Semczuk A; Stenzel A; Baranowski W; Rózynska K; Cybulski M; Kostuch M; Jakowicki J; Wojcierowski J
    Oncol Rep; 2000; 7(4):905-10. PubMed ID: 10854568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of endometrial K-ras mutation in tamoxifen-treated patients with breast cancer.
    Tsujioka H; Hachisuga T; Fukuoka M; Ueda T; Miyahara D; Horiuchi S; Shirota K; Yoshizato T; Emoto M; Miyamoto S; Kawarabayashi T
    Int J Gynecol Cancer; 2009 Aug; 19(6):1052-6. PubMed ID: 19820367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations and amplification of oncogenes in endometrial cancer.
    Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
    Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What is the prognostic importance of molecular genetic factors in endometrial carcinoma?].
    Křepinská E; Chmelařová M; Laco J; Palička V; Spaček J
    Klin Onkol; 2012; 25(4):282-6. PubMed ID: 22920169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of exon 7 PTEN Gene in Endometrial Carcinoma.
    Kafshdooz L; Kafshdooz T; Tabrizi AD; Mohaddes Ardabili SM; Akbarzadeh A; Gharesouran J; Ghojazadeh M; Farajnia S
    Asian Pac J Cancer Prev; 2015; 16(11):4521-4. PubMed ID: 26107197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
    Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
    Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
    Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.
    Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK
    Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
    Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X
    Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium.
    Mizuuchi H; Nasim S; Kudo R; Silverberg SG; Greenhouse S; Garrett CT
    Cancer Res; 1992 May; 52(10):2777-81. PubMed ID: 1581890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
    Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
    Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
    Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer.
    Pan ZZ; Wan DS; Chen G; Li LR; Lu ZH; Huang BJ
    World J Gastroenterol; 2004 Dec; 10(24):3688-90. PubMed ID: 15534934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.